Denison steps up to CEO to steer Congenica growth
Robert Denison, who has been acting as chief information officer for Cambridge digital health doyen Congenica, has stepped up to the chief executive role to steer the next phase of growth. He also joins the board.
Congenica enables precision medicine through its world-leading diagnostic decision support platform for genomic data.
Denison has a strong history of growing businesses – ranging from startups through to high growth multi-billion-dollar organisations.
He joined Congenica as CIO in September 2019 and has since led the transformation of its core technology into a robust, cloud-based diagnostic data analysis and interpretation platform incorporating advanced AI and automation.
He also played a pivotal role in Congenica’s $50 million Series C fundraise. As CEO, Rob will be leading Congenica on its journey towards democratising precision medicine at scale and delivering patient-led data processing and analytics.
He said: “I am delighted to accept the role of CEO at Congenica at what is a very exciting time for the business. Congenica is a global leader in genomics data analysis, working with the leading national genome programs and clinical laboratories across the world.
“With an excellent team in place, and supported by a global network of partners, we are well positioned to deliver on our mission of enabling access to precision medicine for all.”
Chairman Andy Richards added: “Rob is a highly accomplished leader who has demonstrated a deep commitment to Congenica. Under his leadership as CIO he has positioned Congenica at the forefront of genomics data analysis.
“The board is delighted that he has agreed to join as CEO and oversee Congenica’s continued growth and look forward to working with him as a director and member of the board.”